Work

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer

Year: 1997

Type: article

Source: The Prostate

DOI: 10.1002/(sici)1097-0045(19970901)32:4<246::aid-pros4>3.0.co;2-h

Authors: Thambi Dorai, Carl A. Olsson, Aaron E. Katz, Ralph Buttyan

Institutions: Columbia University Irving Medical Center, Columbia University

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: T.J. Martell Foundation

OpenAlex ID: W2027498717

FWCI: 4.504

Cites: 43

Cited by: 82

Related to: 10